𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia

✍ Scribed by Lawrence Panasci; George Shenouda; Louis Begin; Michael Pollak; Ainslie Reinke; Richard Margolese

Publisher
Springer
Year
1990
Tongue
English
Weight
342 KB
Volume
26
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of vincristine, mitomycin
Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity
✍ Timothy J. Perren; George Blackledge; John J. Mould; Anula Dharmapriya Chetiyawa πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 310 KB

Nineteen patients with advanced, previously treated breast cancer received treatment with vincristine 2 mg i.v., mitomycin-C 6 mg/m2 and mitoxantrone (Novantrone; dihydroxyanthracenedione) 12 mg/m2 i.v. every three weeks. Thirteen patients are evaluable for response and toxicity. Partial remission w

Anatomical basis of intra-arterial chemo
Anatomical basis of intra-arterial chemotherapy for patients with locally advanced breast cancer
✍ Ms J. C. Doughty; D. H. A. McCarter; E. Kane; A. W. Reid; T. G. Cooke; C. S. McA πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 306 KB πŸ‘ 2 views

Twenty-eight patients with locally advanced breast cancer per cent. In 33 per cent of patients the lateral thoracic received four doses of regional chemotherapy via artery did not contribute to breast perfusion and a large angiographically placed percutaneous catheters into the area of the lateral a